Tick season is here: How to avoid ticks

Blue Cross Blue Shield of Louisiana is tak­ing Bris­tol My­ers Squibb to court over what it al­leges to be an un­law­ful mo­nop­oly for the can­cer

John­son & John­son In­no­v­a­tive Med­i­cine (JJIM), for­mer­ly known as Janssen, is ear­mark­ing €580 mil­lion ($622 mil­lion) in in­vest­ments in Italy over the next five years

Share this article TERN-701 is an oral allosteric BCR-ABL tyrosine kinase inhibitor (TKI). Image Credit: crystal light / Shutterstock. The US Food and Drug Administration